<DOC>
	<DOC>NCT00963183</DOC>
	<brief_summary>The aim of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5423 following single ascending dose administrations in healthy male subjects.</brief_summary>
	<brief_title>AZD5423 Single Ascending Dose Study</brief_title>
	<detailed_description />
	<criteria>Provision of signed, written and dated informed consent prior to any study specific procedures Have a body mass index (BMI) between 18 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg Any clinically significant disease or disorder Any clinically significant abnormalities at screening examination Use of any prescribed or nonprescribed medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Healthy</keyword>
	<keyword>Inhalation</keyword>
</DOC>